Twitter-Delivered CME/CE on
Chronic Kidney Disease from @ckd_ce
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. This is particularly important in the care of patients with or at risk for CKD, as this has become a multidisciplinary and interprofessional focus. Kidney health is now linked not only pathophysiologically but also by treatment strategies that target diverse cardiovascular outcomes as well as renal health. These issues are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Efficacy and Safety of HIF-PHIs
2) Follow this 🧵for your credit!Statement of accreditation and faculty disclosures are at https://t.co/PHlIppl6Yw. This program is intended for...
Anemia of CKD: Pathophysiology
2) Follow this 🧵for your credit!Statement of accreditation and faculty disclosures are at https://t.co/PHlIppl6Yw. This program is intended for...
Primary Hyperoxaluria Type 1 (pediatric focus)
2) They will be discussing Primary #Hyperoxaluria Type 1, with a #pediatric focus.#nephtwitter #FOAMed #MedTwitter @MedTweetorials #ThisIsISN...
Clinical Trial Data for Nonsteroidal MRA Therapy in Patients with Advancing CKD in the Setting of T2D
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC.#FOAMed #nephtwitter #cardiotwitter @MedTweetorials...
Screening for CKD in Patients with T2D: Microalbuminuria
2) Christos Argyropoulos MD, PhD @ChristosArgyrop is Division Chief, Nephrology @UNMHSC. #CKD is chronic #kidneydisease, #ESKD is end-stage kidney...
MRAs for potential renoprotection in CKD
1b) .@edgarvlermamd will be reviewing the mechanism of action #MOA of #mineralocorticoid receptor antagonists #MRAs in potential #renoprotection for...
Individualized strategies to risk-stratify, manage, and educate patients with advancing CKD in the setting of T2D
2) This #tweetorial is supported by an unrestricted educational grant from Bayer and is intended for healthcare providers.— @CKD_ce (@ckd_ce)...
Journal Club: Underprescribing vs Underfilling in Oral Anticoagulation for SPAF
1b) #CKD is an independent risk factor for subsequent #AFib. Management of #AF can be quite challenging in pts with CKD, and medical therapy for...
Current and Emerging Therapies in the Management of ADPKD
2) This #accredited #tweetorial series on #ADPKD and emerging therapies is supported by an independent educational grant from Otsuka Pharmaceuticals...
Nonclinical Considerations in the Management of ADPKD in Childhood
1b) .@KidneyCathy, our famous international expert, is @UCDMedicine grad, trained @CHI_Ireland @GreatOrmondSt working @MCRI_for_kids @RCHMelbourne...
@CKD_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @ckd_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.